Claudia Erpelinck-Verschueren

8PUBLICATIONS
76CO-AUTHORS
Medical mycologyHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Jan 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Jul 07, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia.

Roger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel

|Sep 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

Sophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren

Pageof 2